Tag: Generics

A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.

Sandoz to Undergo Workforce Reorganization

Sandoz
Sandoz announces plans for a leaner and more efficient global organization, to drive cost competitiveness as the first stage of its ongoing strategic Transformation and support investments into future...

Sandoz Receives Generic Approval for Rosuvastatin in China

Sandoz
Sandoz today announced that it has received regulatory approval from China's National Medical Products Administration (NMPA) for its generic Rosuvastatin, under the NMPA's Quality Consistency Evaluati...

Teva Launched Generic Version of Tarceva®

Teva Pharmaceutical Industries Ltd. announced the launch of a generic version of Tarceva® (erlotinib) tablets, 100 and 150 mg, in the U.S. Erlotinib Tablets are a kinase inhibitor indicated for the...

Nativa Won Several Legal Disputes over Pfizer

The issuing of a compulsory license for the production of a patent-protected drug in Russia may take place shortly, due to the recent victory of several legal disputes with US pharma giant Pfizer by l...

Oakrum Pharma Agreed With Biophore India to Develop Generics

Oakrum Pharma, LLC has entered an agreement with Biophore India Pharmaceuticals Pvt. Ltd. to develop and manufacture two prescription generic pharmaceuticals for commercialization in the U.S. under th...

Сomparative Outcomes of Generics and Brand-Name Meds

A recent study provides evidence that the use of generic medications for chronic conditions is associated with comparable clinical outcomes to the use of brand-name products. Although generic versi...

Teva Launched Generic of EXJADE®

Teva Pharmaceutical Industries Ltd., announced the launch of a generic version of EXJADE® (deferasirox) Tablets for Oral Suspension, 125 mg, 250 mg and 500 mg, in the U.S. Deferasirox Tablets for O...

Teva to Launch Generis of Novo Nordisk Non-Insulin Med

Novo Nordisk today announced that a settlement between Novo Nordisk and Teva Pharmaceuticals USA, Inc. (Teva) has been reached on the US patent litigation case for Victoza® (liraglutide). Consequently...

FDA Approved Lupin’s Generic of Pfizer to Market

Pharma major Lupin announced that it has received approval for its Atorvastatin Calcium Tablets USP, 10 mg, 20 mg, 40 mg, and 80 mg, from the United States Food and Drug Administration (FDA) to market...

FDA Approved New Generic of Valsartan

The U.S. Food and Drug Administration approved a new generic of Diovan (valsartan). Valsartan is an angiotensin II receptor blocker (ARB) that treats high blood pressure and heart failure. The FDA pri...

Glenmark’s Generic Approved by FDA

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Telmisartan and Hydrochlorothiazide Tablets USP, 40 mg/...

Lilly Launches Low-Priced Insulin

Authorized generic version of Humalog will be available in U.S. pharmacies at 50 percent lower list price. Reinforcing the commitment to lower out-of-pocket costs for people who need insulin, Eli L...

FDA Answers about Safety of Generics

In a statement, FDA Commissioner Scott Gottlieb laid out the case for the safety and effectiveness of generic drugs compared to brand drugs. In response to news reports that questioned the safety a...

Indivior Launches Generic of SUBOXONE®

Indivior PLC announced that its U.S. affiliate, Indivior Inc., has launched an authorized generic version of SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII) in the U.S. The authorized ge...

Dr. Reddy’s Launched Generic of Adcirca

Dr. Reddy’s Laboratories Ltd., along with its subsidiaries together referred to as “Dr. Reddy’s” announced the launch of Tadalafil Tablets USP, a therapeutic equivalent generic version of Adcirca (tad...

USP Announced Generics Access Plan

USP announced its Generics Access Plan, helping to increase access to medicines by facilitating generics competition through new and revised quality standards and related activities, including collabo...